These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 7504301

  • 1. Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes.
    Bartfai T, Langel U, Bedecs K, Andell S, Land T, Gregersen S, Ahrén B, Girotti P, Consolo S, Corwin R.
    Proc Natl Acad Sci U S A; 1993 Dec 01; 90(23):11287-91. PubMed ID: 7504301
    [Abstract] [Full Text] [Related]

  • 2. New high affinity peptide antagonists to the spinal galanin receptor.
    Xu XJ, Wiesenfeld-Hallin Z, Langel U, Bedecs K, Bartfai T.
    Br J Pharmacol; 1995 Oct 01; 116(3):2076-80. PubMed ID: 8640348
    [Abstract] [Full Text] [Related]

  • 3. Galanin receptor antagonists M40 and C7 block galanin-induced feeding.
    Crawley JN, Robinson JK, Langel U, Bartfai T.
    Brain Res; 1993 Jan 15; 600(2):268-72. PubMed ID: 7679604
    [Abstract] [Full Text] [Related]

  • 4. Binding and agonist/antagonist actions of M35, galanin(1-13)-bradykinin(2-9)amide chimeric peptide, in Rin m 5F insulinoma cells.
    Kask K, Berthold M, Bourne J, Andell S, Langel U, Bartfai T.
    Regul Pept; 1995 Nov 10; 59(3):341-8. PubMed ID: 8577939
    [Abstract] [Full Text] [Related]

  • 5. The novel high-affinity antagonist, galantide, blocks the galanin-mediated inhibition of glucose-induced insulin secretion.
    Lindskog S, Ahrén B, Land T, Langel U, Bartfai T.
    Eur J Pharmacol; 1992 Jan 14; 210(2):183-8. PubMed ID: 1376272
    [Abstract] [Full Text] [Related]

  • 6. Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor.
    Wynick D, Smith DM, Ghatei M, Akinsanya K, Bhogal R, Purkiss P, Byfield P, Yanaihara N, Bloom SR.
    Proc Natl Acad Sci U S A; 1993 May 01; 90(9):4231-5. PubMed ID: 7683428
    [Abstract] [Full Text] [Related]

  • 7. The galanin receptor antagonist M40 blocks the central cardiovascular actions of the galanin N-terminal fragment (1-15).
    Narváez JA, Díaz-Cabiale Z, Hedlund PB, Aguirre JA, Coveñas R, González-Barón S, Fuxe K.
    Eur J Pharmacol; 2000 Jul 07; 399(2-3):197-203. PubMed ID: 10884520
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. N-terminal galanin-(1-16) fragment is an agonist at the hippocampal galanin receptor.
    Fisone G, Berthold M, Bedecs K, Undén A, Bartfai T, Bertorelli R, Consolo S, Crawley J, Martin B, Nilsson S.
    Proc Natl Acad Sci U S A; 1989 Dec 07; 86(23):9588-91. PubMed ID: 2594786
    [Abstract] [Full Text] [Related]

  • 11. Possible evidence for endogenous production of a novel galanin-like peptide.
    Wang ZL, Kulkarni RN, Wang RM, Smith DM, Ghatei MA, Byfield PG, Bennet WM, Bloom SR.
    J Clin Invest; 1997 Jul 01; 100(1):189-96. PubMed ID: 9202071
    [Abstract] [Full Text] [Related]

  • 12. Galanin receptor antagonist M40 blocks galanin-induced choice accuracy deficits on a delayed-nonmatching-to-position task.
    McDonald MP, Crawley JN.
    Behav Neurosci; 1996 Oct 01; 110(5):1025-32. PubMed ID: 8919005
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of the putative galanin receptor antagonists M15 and M35 on striatal acetylcholine release.
    Ogren SO, Pramanik A, Land T, Langel U.
    Eur J Pharmacol; 1993 Sep 21; 242(1):59-64. PubMed ID: 7693496
    [Abstract] [Full Text] [Related]

  • 14. Impact of a galanin antagonist on exogenous galanin and natural patterns of fat ingestion.
    Leibowitz SF, Kim T.
    Brain Res; 1992 Dec 18; 599(1):148-52. PubMed ID: 1283559
    [Abstract] [Full Text] [Related]

  • 15. Biological activities of two endogenously occurring N-terminally extended forms of galanin in the rat spinal cord.
    Bedecs K, Langel U, Xu XJ, Wiesenfeld-Hallin Z, Bartfai T.
    Eur J Pharmacol; 1994 Jul 01; 259(2):151-6. PubMed ID: 7525314
    [Abstract] [Full Text] [Related]

  • 16. L-Ala-substituted rat galanin analogs distinguish between hypothalamic and jejunal galanin receptor subtypes.
    Juréus A, Langel U, Bartfai T.
    J Pept Res; 1997 Mar 01; 49(3):195-200. PubMed ID: 9151252
    [Abstract] [Full Text] [Related]

  • 17. Dual action of the neuropeptide galanin on the cytoplasmic free calcium concentration in RIN m5F cells.
    Fridolf T, Ahrén B.
    Biochem Biophys Res Commun; 1993 Mar 31; 191(3):1224-9. PubMed ID: 7682064
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Galanin-(1-15), but not galanin-(1-29), modulates 5-HT1A receptors in the dorsal hippocampus of the rat brain: possible existence of galanin receptor subtypes.
    Hedlund PB, Finnman UB, Yanaihara N, Fuxe K.
    Brain Res; 1994 Jan 14; 634(1):163-7. PubMed ID: 7512426
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.